Press release
Adult Malignant Glioma Therapeutics Market Projected to Reach from US$ 1.3 Bn to US$ 2.9 Billion by 2026 with a 9.2% CAGR | Exclusive Report By TMR
Adult Malignant Glioma Therapeutics
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13211
Understanding Adult Malignant Glioma Therapeutics
Malignant gliomas, including glioblastoma multiforme (GBM) and anaplastic astrocytoma, are primary brain tumors in adults characterized by rapid growth and resistance to treatment. Therapeutics include chemotherapy (e.g., temozolomide), targeted therapies (e.g., bevacizumab), radiation-enhancing agents, and emerging immunotherapies. The market's 2017 valuation of US$1.3 billion highlights its established foundation, with the projected rise to US$2.9 billion by 2026 emphasizing its growing importance amid limited survival outcomes and evolving treatment paradigms.
The 9.2% CAGR signals a dynamic growth phase, fueled by innovation and unmet medical needs. Gliomas' complexity drives a robust therapeutic pipeline, ensuring sustained market momentum.
Key Drivers of Market Growth
Several factors are propelling the adult malignant glioma therapeutics market toward its US$2.9 billion valuation by 2026. First, the rising incidence of brain tumors is a key driver. Aging populations and improved diagnostics-like MRI and molecular profiling-are increasing detection rates, with GBM being the most common and lethal form. This growing patient pool, coupled with high mortality, fuels demand for novel therapies, aligning with the market's 9.2% CAGR.
Second, advancements in treatment modalities are accelerating growth. Beyond standard chemoradiation, targeted therapies inhibiting angiogenesis (e.g., VEGF inhibitors) and tumor growth pathways (e.g., EGFR inhibitors) offer new hope. Immunotherapies, including checkpoint inhibitors and personalized vaccines, are gaining traction, supported by breakthroughs in understanding glioma immunology. These innovations drive the market toward US$2.9 billion, addressing resistance to conventional treatments.
Third, increased R&D investment and regulatory support are boosting the market. Pharmaceutical companies, backed by government grants and fast-track designations from agencies like the FDA, are prioritizing glioma research. Orphan drug status for rare cancers incentivizes development, enhancing the pipeline and supporting the market's significant growth trajectory through 2026.
Leading Players:
Merck & Co. Inc.
F. Hoffmann-La Roche Ltd.
Arbor Pharmaceuticals
Pfizer Inc.
AbbVie Inc.
Amgen Inc.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Limited
and Emcure Pharmaceuticals Limited.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13211
Market Segmentation and Regional Insights
The market segments by therapy type, glioma type, and geography. Chemotherapy dominates, led by temozolomide, while targeted therapies and immunotherapies are fast-growing segments due to precision and efficacy. GBM holds the largest share, reflecting its prevalence, with anaplastic gliomas as a smaller but critical subset. Distribution occurs via hospitals, oncology centers, and pharmacies, with hospitals leading due to complex treatment needs.
Regionally, North America accounted for a significant portion of the US$1.3 billion valuation in 2017, driven by advanced healthcare systems, high R&D spending, and strong patient awareness in the United States. Europe followed, with robust markets in Germany and the UK, supported by universal healthcare. The Asia-Pacific region, however, was poised for the fastest growth through 2026, fueled by rising healthcare access, increasing cancer awareness, and research investments in China and Japan.
Challenges and Opportunities
The market faced challenges during this period. High treatment costs and limited efficacy-median survival for GBM remains under 15 months-restricted adoption. Adverse effects, such as neurotoxicity or immunosuppression, complicated therapy, while regulatory hurdles and small patient populations slowed drug approvals. Generic competition for established drugs also pressured pricing.
These challenges, however, presented opportunities. Companies developing cost-effective alternatives or combination therapies could improve outcomes, supporting the push to US$2.9 billion. Innovations like tumor-treating fields (TTFields) or gene therapies offered potential breakthroughs, while expanding clinical trials in emerging markets broadened access. Partnerships with biotech firms could exceed projections, targeting resistant gliomas.
The Road to 2026
By 2026, the global adult malignant glioma therapeutics market reached its projected US$2.9 billion, reflecting nine years of strong growth at a 9.2% CAGR from US$1.3 billion in 2017. This achievement was driven by rising incidence, therapeutic innovation, and global efforts. As the forecast period concluded, the market's trajectory suggested continued momentum, with potential for immunotherapy and precision medicine to shape future advances.
In conclusion, the adult malignant glioma therapeutics market demonstrated remarkable growth from 2018 to 2026. Rising from US$1.3 billion to US$2.9 billion, it addressed a dire health challenge with transformative potential. Stakeholders-from researchers to pharma firms-played a vital role in this success, ensuring that innovative solutions reached patients through 2026 and beyond.
Explore Latest Research Reports by Transparency Market Research:
Veterinary Ventilators Market: https://www.pharmiweb.com/press-release/2025-03-18/veterinary-ventilators-market-to-surpass-us-13-bn-by-2035-amid-rising-demand-for-advanced-animal-healthcare-solutions-tmr-research
Wearable Pulse Oximeters Market: https://www.pharmiweb.com/press-release/2025-03-18/wearable-pulse-oximeters-market-to-surpass-us-5945-mn-by-2031-amid-rising-demand-for-smart-health-monitoring-solutions-tmr-research
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adult Malignant Glioma Therapeutics Market Projected to Reach from US$ 1.3 Bn to US$ 2.9 Billion by 2026 with a 9.2% CAGR | Exclusive Report By TMR here
News-ID: 3960811 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for US$2
Industrial Automation Market to Reach US$345.73 Bn by 2031, Driven by Smart Tech …
✅Industrial Automation Market: Transforming the Future of Manufacturing and Efficiency
Overview of the Market
The global industrial automation market is witnessing a profound transformation driven by the increasing demand for operational efficiency, reduced human intervention, and technological advancements. Valued at US$184.34 billion in 2024, the market is projected to surge to US$345.73 billion by 2031, registering a robust CAGR of 9.4% during the forecast period. This growth reflects the widespread adoption of…
Texturized Vegetable Protein Market Worth US$ 2 Bn by 2029
The global Texturized Vegetable Protein market is estimated to attain a valuation of US$ 2 Bn by the end of 2029, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2019 - 2029.
The key objective of the TMR report is to offer a complete assessment of the global market…
N-Methyl-2-Pyrrolidone Market worth US$ 2 Billion by 2027
N-Methyl-2-Pyrrolidone Market: Key Highlights
The N-methyl-2-pyrrolidone (NMP) market was valued at ~US$ 1.1 Bn in 2018, and is anticipated to expand at a CAGR of ~6.0% from 2019 to 2027.
The global N-methyl-2-pyrrolidone market is driven by the rise in the demand for N-methyl-2-pyrrolidone from the electronics industry.
In terms of value, the N-methyl-2-pyrrolidone market in Asia Pacific is expected to expand at a CAGR of ~8% during the forecast period. China is…
N-Methyl-2-Pyrrolidone in Cosmetics worth US$ 2 Billion by 2027
N-Methyl-2-Pyrrolidone Market Holds Multichannel Revenue Opportunities
The sales of consumer electronics are showing no signs of slowing down, implying that, manufacturers of electronic devices are investing toward the development of smart-sized products with better functionalities, which manages to attract the attention of consumers.
Read report Overview-
https://www.transparencymarketresearch.com/n-methyl-2-pyrrolidone-nmpo-market.html
Investments made in the consumer electronics market, are, in turn, creating opportunities for the N-methyl-2-pyrrolidone market, given the rising demand for lithium batteries. According to stats published…
Blockchain Certification Company Lands US $2 Million Investment
Blockchain is growing, the crypto markets are booming but a serious problem which has now started hurting the whole industry is the involvement of a limited number of people who are currently running the show. More than blockchain literacy, we have developers, traders and investors who are driven by misinformation as there is no set standard in the industry to follow.
The whole blockchain is based on open source code and…
Liquid Biopsy Market Worth US$ 2 Billion by 2022
New York, April 24: Market Research Engine has published a new report titled as “Liquid Biopsy Market By Type of Cancer Analysis (Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Liver Cancer); By Product and services Analysis (Instruments, Services and Software, Reagents); By Circulation Biomarkers Analysis (Circulating Tumor Cells (CTCs), Extracellular Vesicles (EVs), Circulating Tumor DNA (ctDNA)); By End User Analysis (academic & Research Centers, Reference Laboratories, Hospital and Physician…
